Most people on Mounjaro start losing weight within the first month, with research showing around 4% of starting body weight lost in the initial four weeks. But meaningful, larger results take longer. In clinical trials, participants lost about 7% by week 12, roughly 20% by week 72, and the drug continued working for some people beyond that point. Your personal timeline depends on your dose, starting weight, and whether you pair the medication with diet and exercise changes.
What to Expect in the First Month
Mounjaro starts at a low dose of 2.5 mg per week, which is designed to let your body adjust rather than deliver maximum weight loss. Even at this introductory dose, participants in clinical studies lost around 4% of their starting body weight in four weeks. For someone weighing 250 pounds, that translates to roughly 10 pounds. The weight loss at this stage comes primarily from reduced appetite and eating less overall, not from the drug operating at full strength.
The 2.5 mg dose isn’t meant to be your long-term dose. After four weeks, your prescriber will increase it to 5 mg, and from there it can go up in 2.5 mg increments every four weeks until you reach the target dose, which can be as high as 15 mg. Reaching the maximum dose takes at least 20 weeks if you move through every step on schedule. Many people notice their weight loss accelerating as they climb through the higher doses.
The 3- to 6-Month Window
The period between months three and six is where the most dramatic changes tend to happen. By week 12, participants in the SURMOUNT-3 trial had lost an average of 6.9% of their body weight, about 16.8 pounds. This is also the window where most people reach or approach their therapeutic dose, so the medication’s appetite-suppressing effects are near full strength.
If you’re in the overweight category (a BMI between 27 and 30), weight loss may plateau as early as 24 weeks. People with class I obesity tend to plateau around 26 weeks. Those with higher starting weights, in class II or III obesity, often keep losing at a steady pace until around 36 weeks. This makes intuitive sense: people with more weight to lose generally lose it over a longer period before the body adjusts.
Results After One Year and Beyond
The landmark SURMOUNT-1 trial followed participants for 72 weeks, about a year and a half. Those on the highest dose (15 mg) lost an average of 20.9% of their body weight compared to a placebo group. In a separate trial that combined the medication with intensive lifestyle changes (structured diet and exercise), participants lost a total of 26.6% of their starting weight over 84 weeks, roughly 64 pounds on average.
By week 72, approximately 88 to 90% of participants across all weight categories had reached a plateau, meaning their weight had stabilized. Certain factors predicted a longer, more extended period of weight loss before hitting that plateau: being on the 10 or 15 mg dose, being younger, and being female. If you’ve been on Mounjaro for a year and your weight has leveled off, that’s the expected pattern, not a sign the drug has stopped working.
Why Mounjaro Works Faster Than Older Medications
Mounjaro activates two hormone receptors involved in appetite and metabolism, while older weight loss injections like semaglutide (Wegovy, Ozempic) only activate one. In head-to-head comparisons, all three doses of Mounjaro outperformed the highest approved dose of semaglutide for both weight loss and blood sugar control. The dual-receptor approach also appears to cause less receptor burnout over time, which may help explain why the drug remains effective at higher doses for longer periods.
People with type 2 diabetes tend to lose less weight on Mounjaro than those without diabetes. The SURMOUNT-2 trial, which enrolled participants with both obesity and type 2 diabetes, showed a 12.4% weight difference from placebo at the 15 mg dose. That’s still substantial, but noticeably less than the 17.8% difference seen in the general obesity population.
How Diet and Exercise Change the Numbers
Mounjaro is FDA-approved specifically as a companion to a reduced-calorie diet and increased physical activity, not as a standalone treatment. The data backs up why. In the SURMOUNT-3 trial, participants first completed 12 weeks of intensive lifestyle changes (losing at least 5% of their weight through diet and exercise alone), then added tirzepatide. Those who got the medication lost an additional 18.4% of their body weight over the following 72 weeks, while those on placebo actually regained about 2.5%. The total weight loss for the medication group reached 26.6%, compared to roughly 17.8% in trials where lifestyle changes were less structured.
This doesn’t mean you need a rigid program to benefit. But the evidence is clear that the people who lose the most weight on Mounjaro are the ones who also change what and how much they eat.
What Happens if You Stop
Weight regain after stopping Mounjaro is significant and well-documented. In the SURMOUNT-4 trial, participants who had lost at least 10% of their body weight over 36 weeks were then split into two groups: one continued the medication, the other switched to a placebo. Among those who stopped, 82% regained more than 25% of the weight they had lost within one year. About a third regained 50 to 75% of their lost weight, and roughly a quarter gained back 75% or more.
Only a small group, 54 out of 308 people, managed to keep their regain below 25% of what they’d lost. This is consistent with the broader understanding that obesity is a chronic condition requiring ongoing treatment. For most people, Mounjaro is not a short-term fix but a long-term commitment, similar to blood pressure medication that works while you take it.
A Realistic Timeline Summary
- Weeks 1 to 4: Roughly 4% body weight lost on the starter dose. Appetite noticeably reduced for most people.
- Weeks 5 to 12: Dose increases to 5 mg and possibly 7.5 mg. Weight loss accelerates, reaching about 7% by week 12.
- Weeks 12 to 36: Most active weight loss phase, especially at higher doses. People with lower starting weights may plateau around week 24 to 26.
- Weeks 36 to 72: Weight loss continues to slow. Those with higher starting weights may keep losing until week 36 or later. By week 72, roughly 90% of people have reached their plateau.
- Beyond 72 weeks: Weight generally stabilizes. Continued use maintains the loss; stopping leads to substantial regain in most cases.